NO20042870L - Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist - Google Patents

Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist

Info

Publication number
NO20042870L
NO20042870L NO20042870A NO20042870A NO20042870L NO 20042870 L NO20042870 L NO 20042870L NO 20042870 A NO20042870 A NO 20042870A NO 20042870 A NO20042870 A NO 20042870A NO 20042870 L NO20042870 L NO 20042870L
Authority
NO
Norway
Prior art keywords
combination
receptor antagonist
pde4 inhibitor
adrenergic beta
selective pde4
Prior art date
Application number
NO20042870A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Yeadon
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20042870L publication Critical patent/NO20042870L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
NO20042870A 2001-12-07 2004-07-06 Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist NO20042870L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0129395.0A GB0129395D0 (en) 2001-12-07 2001-12-07 Pharmaceutical combination
PCT/IB2002/004922 WO2003047578A1 (fr) 2001-12-07 2002-11-22 Combinaison d'un inhibiteur selectif de pde4 et d'un agoniste des recepteurs beta-2 adrenergiques

Publications (1)

Publication Number Publication Date
NO20042870L true NO20042870L (no) 2004-07-06

Family

ID=9927247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042870A NO20042870L (no) 2001-12-07 2004-07-06 Kombinasjon av en selektiv PDE4-inhibitor og en adrenerg beta-2-reseptorantagonist

Country Status (33)

Country Link
US (2) US20030119862A1 (fr)
EP (1) EP1455783A1 (fr)
JP (1) JP2005511657A (fr)
KR (1) KR20050044699A (fr)
CN (1) CN1599609A (fr)
AP (1) AP2004003054A0 (fr)
AR (1) AR037712A1 (fr)
AU (1) AU2002353255A1 (fr)
BR (1) BR0214776A (fr)
CA (1) CA2468676A1 (fr)
CO (1) CO5590899A2 (fr)
EA (1) EA200400640A1 (fr)
EC (1) ECSP045142A (fr)
GB (1) GB0129395D0 (fr)
HN (1) HN2002000356A (fr)
HR (1) HRP20040515A2 (fr)
HU (1) HUP0402546A3 (fr)
IL (1) IL162098A0 (fr)
IS (1) IS7277A (fr)
MA (1) MA27152A1 (fr)
MX (1) MXPA04004930A (fr)
NO (1) NO20042870L (fr)
NZ (1) NZ533030A (fr)
OA (1) OA12736A (fr)
PA (1) PA8560601A1 (fr)
PE (1) PE20031066A1 (fr)
PL (1) PL370770A1 (fr)
SV (1) SV2004001430A (fr)
TN (1) TNSN04102A1 (fr)
TW (1) TWI242433B (fr)
UY (1) UY27564A1 (fr)
WO (1) WO2003047578A1 (fr)
ZA (1) ZA200403905B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
DE10360954B3 (de) * 2003-12-23 2005-08-18 Esparma Gmbh Verwendung von Silibinin, dessen Salzen und/oder dessen Prodrugs zusammen mit α-Liponsäure zur Behandlung chronisch obstruktiver Lungenerkrankungen
WO2012098495A1 (fr) * 2011-01-19 2012-07-26 Glenmark Pharmaceuticals Sa Composition pharmaceutique qui comprend le revamilast et un agoniste de bêta-2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69525978T2 (de) * 1995-06-06 2002-12-19 Pfizer Trizyclische 5,6-dihydro-9h-pyrazolo(3,4-c)-1,2,4-triazolo(4,3-alpha)pyridine
CZ293735B6 (cs) * 1998-08-26 2004-07-14 Smithkline Beecham Corporation Farmaceutický prostředek pro léčbu plicní nemoci
CA2715683A1 (fr) * 1999-08-21 2001-03-01 Nycomed Gmbh Combinaison synergiste

Also Published As

Publication number Publication date
EA200400640A1 (ru) 2004-12-30
MXPA04004930A (es) 2005-04-08
WO2003047578A1 (fr) 2003-06-12
CA2468676A1 (fr) 2003-06-12
ZA200403905B (en) 2005-06-22
PA8560601A1 (es) 2005-02-04
HRP20040515A2 (en) 2004-10-31
KR20050044699A (ko) 2005-05-12
BR0214776A (pt) 2004-11-09
PL370770A1 (en) 2005-05-30
OA12736A (en) 2006-06-29
HN2002000356A (es) 2003-02-21
ECSP045142A (es) 2004-07-23
EP1455783A1 (fr) 2004-09-15
GB0129395D0 (en) 2002-01-30
AU2002353255A1 (en) 2003-06-17
CN1599609A (zh) 2005-03-23
PE20031066A1 (es) 2003-12-24
TWI242433B (en) 2005-11-01
SV2004001430A (es) 2004-02-24
TW200300678A (en) 2003-06-16
UY27564A1 (es) 2003-07-31
HUP0402546A3 (en) 2008-04-28
TNSN04102A1 (fr) 2006-06-01
JP2005511657A (ja) 2005-04-28
CO5590899A2 (es) 2005-12-30
US20040167153A1 (en) 2004-08-26
MA27152A1 (fr) 2005-01-03
IS7277A (is) 2004-05-21
US20030119862A1 (en) 2003-06-26
AP2004003054A0 (en) 2004-06-30
AR037712A1 (es) 2004-12-01
HUP0402546A2 (hu) 2005-04-28
IL162098A0 (en) 2005-11-20
NZ533030A (en) 2007-03-30

Similar Documents

Publication Publication Date Title
IS7041A (is) 5-HT viðtakabindlar og notkun þeirra
ITTO20030268A1 (it) Apparecchiatura e procedimento di alesatura a
DE60103974D1 (de) Gyrase-inhibitoren und ihre verwendung
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
NO20040248L (no) Blandede metallocenkatalysatorsystemer som inneholder en darlig komonomerinkorporering og en god konomoneringkorporering
NO20035174L (no) Radialt utvidbart r degree relement med underst degree ttet endeparti
NO20023639L (no) Fremgangsmåte og anordninger for å klargjöre brönner
EP1436258A4 (fr) Antagonistes du recepteur nmda dependant du ph
NO20041648L (no) Borebronner og borefluider
NO20025312L (no) Strukturer og fremgangsmåter for å dempe utstyrsbölger, spesielt for akustisk loggeutstyr
DE60134601D1 (de) Kommunikationsdienstverfahren und Kommunikationsgerät dafür
IS8760A (is) Lyfjablanda úr pde4 eða pde3/4 tálma og histamínviðtakamótlyfi
DE60238229D1 (de) Sendevorrichtung und sendeverfahren
NO20042322L (no) Kretsdelkobler, anordning og pakning
NO20024732D0 (no) Ny kombinasjon av en betablokker og et kolesterolsenkende middel
NO20031997D0 (no) CRF-reseptor-antagonist og metoder relatert dertil
NO20023843L (no) Skumanordning og fremgangsmåte
DE60223540D1 (de) Mundschutz und mundschutzfolie
NO20023144D0 (no) Kompleks omfattende OCIF og polysakkarid
FR2836321B1 (fr) Recepteur selectif d'elements d'information
PL370770A1 (en) Combination of a selective pde4 inhibitor and an adrenergic beta-2 receptor agonist
EP1468113A4 (fr) Optineurine et glaucome
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
DE60222015D1 (de) Ccr-3-rezeptorantagonisten vii

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application